Fermented Milk Drink on Human Intestinal Microflora

Status Completed

Clinical Trial Summary

Fermented milk is a popular drink. Recent studies revealed that some fermented milk containing some strains of lactic acid bacteria have health-promoting effects through improvement of the intestinal microflora and modulation of the immune system. Lactobacillus casei strain Shirota (LcS) is a probiotic bacterium used in the production of fermented milk products and lactic acid bacteria preparations. LcS has been shown to modify allergen-induced immune responses in allergic rhinitis, altering fermentation patterns in the small bowel, prevention of recurrent urinary tract infections in women. Yakult®300 is a fermented milk containing at least 3x10^10 live LcS cells per 100 ml bottle. This study aimed to evaluate the effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the human intestinal microflora.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Basic Science

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00822328
Study type	Interventional
Source	Cheng Hsin Rehabilitation Medical Center
Contact
Status	Completed
Phase	Phase 2
Start date	January 2009
Completion date	March 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02530762` - Acute Gastrointestinal Tolerability Following a Single Serving of a Novel Dietary Fiber	N/A
Completed	`NCT02532985` - Gastrointestinal Tolerability Following Multiple Servings of a Novel Dietary Fiber	N/A
Recruiting	`NCT01464814` - Clinical Trial Evaluating the Viability of L. Casei + Fish Oil Capsules	N/A
Completed	`NCT02180035` - Treatment With Nutritional Eating Plan and Dietary Fibers in Adult Patients With HIV/AIDS	N/A
Completed	`NCT05603403` - Efficacy And Safety Of Probiatop In The Treatment Of Digestive Symptoms	Phase 4
Recruiting	`NCT02928484` - Evaluation of the Effect of a Probiotic Supplement Upon Gastrointestinal Function	Phase 1/Phase 2
Completed	`NCT02519374` - Fiber Tolerability in Children	N/A
Completed	`NCT02677090` - Fiber Tolerability in Children Aged 3-7 Year	N/A
Completed	`NCT02253628` - The Acute Effect of Coffee Consumption on Stomach, Self-reported Gastrointestinal Symptoms and Stress.	N/A
Completed	`NCT00251914` - Nexium Dyspepsia/AST	Phase 3
Completed	`NCT00251992` - Nexium Dyspepsia/AST	Phase 3
Completed	`NCT01431482` - Evaluation of the Composition of Human Milk and Health Outcomes in Children
Terminated	`NCT01675960` - Effectiveness of Gabapentin on Chronic Irritability in Neurologically Impaired Children	Phase 2
Completed	`NCT00652834` - Small Bowel Capsule Endoscopy Findings in Patients Receiving Cellcept®	Phase 4
Active, not recruiting	`NCT00110708` - Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism	Phase 2